← Home UAE · nd-uae

GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration

Source: en_prnasisa · 2026-10-12T18:45:00 UTC

Linking North American and Asia-Pacific Capabilities to Support Joint Sales and Project Execution SEOUL, South Korea and RALEIGH, N.C., Oct. 13, 2026 /PRNewswire/ -- GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho, announced today that it signed a Memorandum of Understanding (MOU) with LabConnect on October 12 to expand global clinical tri

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration

Related in UAE

Dubai Police warn of limits to online criticism: Comments must not be used to harm others

Dubai schools clarify photography rules: What parents can and cannot do at events

Thunder, dusty winds possible as rain may spread to Dubai this week

Malta Tourism Authority and Trip.com Group Sign Strategic Cooperation Memorandum of Understanding to Promote Malta as a Global Destination

eFinancialCareers collaborates with the Skills and Workforce Development Agency (SWDA) on the Careers and Skills Passport

Arirang TV Showcases the Future of Korea's Sports Innovation to the World